Anti-SMAD6 antibody [EPR24687-21] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Lab
Western blot - Anti-SMAD6 antibody [EPR24687-21] - BSA and Azide free (AB283282)
This data was developed using ab273106, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST. The observed MW & expression profile are consistent with what has been described in the literature (PMID : 19047146; PMID : 9256479).
NCI-H460 was reported for low-abundance for the dominant 62kDa isoform of SMAD6(PMID : 19047146).
Exposure time : 3 minutes.
All lanes:
Western blot - Anti-SMAD6 antibody [EPR24687-21] (<a href='/en-us/products/primary-antibodies/smad6-antibody-epr24687-21-ab273106'>ab273106</a>) at 1/1000 dilution
Lane 1:
NCI-H1299 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
A549 (human lu carcinoma epithelial cell) whole cell lysate 20 at 20 µg
Lane 3:
NCI-H460 (human Large Cell Lu Cancer epithelial cell) whole cell lysate 20 at 20 µg
Lane 4:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 5:
U-87 MG (human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
Neuro-2a (mouse neuroblastoma neuroblast) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 53 kDa
Observed band size: 30 kDa
false
Related conjugates and formulations (1)
-
Anti-SMAD6 antibody [EPR24687-21]
Reactivity data
Product details
ab283282 is the carrier-free version of ab273106.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SMAD6 plays a critical role in modulating BMP signaling. It functions not as part of a larger protein complex but as a direct antagonist to BMP-induced cellular responses. By binding to SMAD1 and SMAD5 SMAD6 impedes the transcriptional activity that promotes various cellular processes such as proliferation differentiation and apoptosis. This regulation is essential for maintaining cellular homeostasis and ensuring proper embryonic development.
Pathways
SMAD6 serves as an important checkpoint within the TGF-beta/BMP signaling pathway. It relates to other proteins such as SMAD7 which also functions as an inhibitory SMAD although SMAD6 is more selective in antagonizing BMP receptors. Through its actions SMAD6 aids in the regulation of processes like bone formation and vascular development. By throttling the BMP pathway SMAD6 maintains a balance between proliferative signals and inhibitory cues important for organogenesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com